Table 1

Baseline characteristics of included trials

StudyYearNDuration (years)BP-SESDP-DES
StentNStentN
Bio-Resort201923423Orsiro1169Resolute Integrity (ZES)1173
BIOSTEMI201913001Orsiro649XIENCE (EES)651
BIOFLOW IV20195751Orsiro385XIENCE (EES)190
BIOFLOW V202013343Orsiro884XIENCE (EES)450
BIOFLOW VI20204401Orsiro220XIENCE (EES)220
BIONYX202024882Orsiro1245Resolute Onyx (ZES)1243
BIOSCIENCE201821195Orsiro1063XIENCE (EES)1056
BIOFLOW II20184525Orsiro298XIENCE (EES)154
ORIENT20193723Orsiro250Resolute Integrity (ZES)122
PRISON IV20173301Orsiro165XIENCE (EES)165
  • BP-SES, biodegradable polymer sirolimus-eluting stent; DP-DES, durable polymer drug-eluting stents; EES, everolimus-eluting stents; ZES, zotarolimus-eluting stents.